Form 4: Recursion Pharmaceuticals Executive David J. Mauro Reports Stock Transaction
SEC Form 4
David J. Mauro, Chief Medical Officer of Recursion Pharmaceuticals, reports a transaction involving the withholding of shares to cover tax obligations.
Summary
- On August 15, 2024, David J. Mauro, the Chief Medical Officer of Recursion Pharmaceuticals, had 14,146 shares of Class A Common Stock withheld by the issuer to cover tax obligations related to the net settlement of restricted stock units.
- The transaction price was $6.69 per share.
- Following the transaction, Mauro directly owns 229,616 shares of Class A Common Stock.
- Mauro also holds options to purchase 99,537 shares at $10.09, vesting monthly from March 1, 2024, and options to purchase 381,426 shares at $8.77, vesting quarterly from June 1, 2024, then monthly.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a small number of shares withheld for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Start date for monthly vesting of options to purchase 99,537 shares at $10.09. |
| 06/01/2024 | Start date for quarterly vesting of options to purchase 381,426 shares at $8.77, then monthly. |
| 08/15/2024 | Date of the stock transaction where 14,146 shares were withheld for tax obligations. |
| 08/19/2024 | Date of the report filing. |
| 02/09/2034 | Expiration date for stock options priced at $10.09. |
| 06/01/2033 | Expiration date for stock options priced at $8.77. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.